Published in Cell Stem Cell on March 06, 2008
Recent progress in the biology and physiology of sirtuins. Nature (2009) 7.73
Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med (2010) 5.76
Cytoplasmic functions of the tumour suppressor p53. Nature (2009) 5.23
Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell (2012) 2.96
Trim24 targets endogenous p53 for degradation. Proc Natl Acad Sci U S A (2009) 2.00
Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell (2012) 1.89
The p53 family and programmed cell death. Oncogene (2008) 1.81
miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) (2010) 1.76
SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell (2014) 1.73
NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. Nat Med (2009) 1.66
p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol (2012) 1.63
Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling. Cell Stem Cell (2012) 1.54
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome. Genes Cancer (2011) 1.54
Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci U S A (2010) 1.48
SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta (2010) 1.46
The dual role of sirtuins in cancer. Genes Cancer (2011) 1.45
miR-34a regulates mouse neural stem cell differentiation. PLoS One (2011) 1.37
SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood (2010) 1.36
Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Cell Death Dis (2013) 1.31
Sirt3 protects in vitro-fertilized mouse preimplantation embryos against oxidative stress-induced p53-mediated developmental arrest. J Clin Invest (2010) 1.27
Upregulation of nascent mitochondrial biogenesis in mouse hematopoietic stem cells parallels upregulation of CD34 and loss of pluripotency: a potential strategy for reducing oxidative risk in stem cells. Cell Cycle (2010) 1.25
Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. Int J Biol Sci (2010) 1.24
Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc Natl Acad Sci U S A (2013) 1.22
Mitochondrial regulation of cell cycle and proliferation. Antioxid Redox Signal (2012) 1.19
SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells (2014) 1.19
A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53. EMBO Mol Med (2012) 1.18
Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol (2012) 1.16
The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin. Diabetes (2011) 1.16
Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate. J Cell Sci (2012) 1.12
Aging-like phenotype and defective lineage specification in SIRT1-deleted hematopoietic stem and progenitor cells. Stem Cell Reports (2014) 1.12
Protein post-translational modifications and regulation of pluripotency in human stem cells. Cell Res (2013) 1.12
Sirtuin 1, stem cells, aging, and stem cell aging. Curr Opin Hematol (2008) 1.11
Stem cells and the impact of ROS signaling. Development (2014) 1.10
Reactive oxygen species in normal and tumor stem cells. Adv Cancer Res (2014) 1.06
Sirt1 ablation promotes stress-induced loss of epigenetic and genomic hematopoietic stem and progenitor cell maintenance. J Exp Med (2013) 1.06
Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence. Biochem Pharmacol (2012) 1.06
Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype. Blood (2012) 1.05
Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain. Nat Cell Biol (2013) 1.03
Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription. J Biomed Biotechnol (2011) 1.03
Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation. J Biol Chem (2009) 1.02
SIRT1 deficiency downregulates PTEN/JNK/FOXO1 pathway to block reactive oxygen species-induced apoptosis in mouse embryonic stem cells. Stem Cells Dev (2011) 1.02
The role of sirtuins in modulating redox stressors. Free Radic Biol Med (2011) 0.99
Metabolic regulation of stem cell function. J Intern Med (2014) 0.97
Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation. Stem Cells (2014) 0.97
p53 in stem cells. World J Biol Chem (2011) 0.95
RUNX Family Participates in the Regulation of p53-Dependent DNA Damage Response. Int J Genomics (2013) 0.95
An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells. Cell Stem Cell (2015) 0.94
High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients. Sci Rep (2014) 0.93
Role of mitochondria in alcoholic liver disease. World J Gastroenterol (2014) 0.93
Sirtuin 1 facilitates generation of induced pluripotent stem cells from mouse embryonic fibroblasts through the miR-34a and p53 pathways. PLoS One (2012) 0.91
SirT1 brings stemness closer to cancer and aging. Aging (Albany NY) (2011) 0.90
The human sirtuin family: evolutionary divergences and functions. Hum Genomics (2011) 0.90
Role of Pax3 acetylation in the regulation of Hes1 and Neurog2. Mol Biol Cell (2010) 0.90
Umbilical cord transplantation: epilogue. Semin Hematol (2010) 0.90
Stem cells, redox signaling, and stem cell aging. Antioxid Redox Signal (2014) 0.89
The importance of NAD in multiple sclerosis. Curr Pharm Des (2009) 0.89
Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med (2013) 0.89
Myeloid deletion of SIRT1 aggravates serum transfer arthritis in mice via nuclear factor-κB activation. PLoS One (2014) 0.88
Cited2 gene controls pluripotency and cardiomyocyte differentiation of murine embryonic stem cells through Oct4 gene. J Biol Chem (2012) 0.87
Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells. Curr Opin Hematol (2015) 0.87
Overexpression of p53 protein in human tumors. Med Mol Morphol (2012) 0.87
Reciprocal roles of SIRT1 and SKIP in the regulation of RAR activity: implication in the retinoic acid-induced neuronal differentiation of P19 cells. Nucleic Acids Res (2009) 0.87
Sirtuins, bioageing, and cancer. J Aging Res (2011) 0.86
SIRT1 is necessary for proficient telomere elongation and genomic stability of induced pluripotent stem cells. Stem Cell Reports (2014) 0.86
MicroRNA-181 regulates CARM1 and histone arginine methylation to promote differentiation of human embryonic stem cells. PLoS One (2013) 0.86
Integrative framework for identification of key cell identity genes uncovers determinants of ES cell identity and homeostasis. Proc Natl Acad Sci U S A (2014) 0.86
Aging and vascular dysfunction: beneficial melatonin effects. Age (Dordr) (2011) 0.85
Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function. Ann N Y Acad Sci (2012) 0.85
Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness. Oncotarget (2015) 0.85
Interaction of OKL38 and p53 in regulating mitochondrial structure and function. PLoS One (2012) 0.84
Sirt1's complex roles in neuroprotection. Cell Mol Neurobiol (2009) 0.84
SIRT1 inhibits the mouse intestinal motility and epithelial proliferation. Am J Physiol Gastrointest Liver Physiol (2011) 0.83
Roles of SIRT1 in leukemogenesis. Curr Opin Hematol (2013) 0.83
Stress Inducibility of SIRT1 and Its Role in Cytoprotection and Cancer. Genes Cancer (2013) 0.83
Insulin/IGF-I and related signaling pathways regulate aging in nondividing cells: from yeast to the mammalian brain. ScientificWorldJournal (2010) 0.83
SIRT1/PARP1 crosstalk: connecting DNA damage and metabolism. Genome Integr (2013) 0.82
SIRT1 Inhibits p53 but not NF-κB Transcriptional Activity during Differentiation of Mouse Embryonic Stem Cells into Embryoid Bodies. Int J Stem Cells (2012) 0.82
Polydatin Alleviates Small Intestine Injury during Hemorrhagic Shock as a SIRT1 Activator. Oxid Med Cell Longev (2015) 0.82
Interferon β protects against lethal endotoxic and septic shock through SIRT1 upregulation. Sci Rep (2014) 0.81
Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity. Stem Cell Reports (2015) 0.81
Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials. Front Med (Lausanne) (2015) 0.81
Sirtuins, a promising target in slowing down the ageing process. Biogerontology (2017) 0.80
The controversial world of sirtuins. Drug Discov Today Technol (2014) 0.80
Sirt1 and the Mitochondria. Mol Cells (2016) 0.80
The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells. Cancer Biol Ther (2016) 0.79
Role of sirtuins in stem cell differentiation. Genes Cancer (2013) 0.79
SirT1--a sensor for monitoring self-renewal and aging process in retinal stem cells. Sensors (Basel) (2010) 0.79
Resveratrol increases the bone marrow hematopoietic stem and progenitor cell capacity. Am J Hematol (2014) 0.79
Resveratrol activates SIRT1 in a Lamin A-dependent manner. Cell Cycle (2013) 0.79
Altered gene expression, mitochondrial damage and oxidative stress: converging routes in motor neuron degeneration. Int J Cell Biol (2012) 0.79
p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53. Cell Death Dis (2015) 0.78
Maintenance of pluripotency in mouse ES cells without Trp53. Sci Rep (2013) 0.78
Regulation of Stem Cell Fate by ROS-mediated Alteration of Metabolism. Int J Stem Cells (2015) 0.78
Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells. Sci Rep (2016) 0.77
Inhibiting HDAC for human hematopoietic stem cell expansion. J Clin Invest (2014) 0.77
A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor. Cell Cycle (2010) 0.77
Imprinted Zac1 in neural stem cells. World J Stem Cells (2015) 0.76
Deciphering the Epigenetic Code in Embryonic and Dental Pulp Stem Cells. Yale J Biol Med (2016) 0.76
Functional Significance of Aurora Kinases-p53 Protein Family Interactions in Cancer. Front Oncol (2016) 0.75
MEK1 signaling promotes self-renewal and tumorigenicity of liver cancer stem cells via maintaining SIRT1 protein stabilization. Oncotarget (2016) 0.75
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A (1993) 20.33
hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 15.97
Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell (2001) 15.05
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (1995) 14.90
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (1998) 11.90
A model for p53-induced apoptosis. Nature (1997) 11.38
PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell (2001) 11.04
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science (2004) 9.52
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A (2003) 9.14
p53 has a direct apoptogenic role at the mitochondria. Mol Cell (2003) 8.98
The antioxidant function of the p53 tumor suppressor. Nat Med (2005) 7.57
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J (2002) 6.37
Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol (2005) 6.34
Regulation of the specific DNA binding function of p53. Cell (1992) 6.16
Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev (2000) 5.90
Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science (2004) 5.88
p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol (2004) 5.82
p53 ubiquitination: Mdm2 and beyond. Mol Cell (2006) 5.57
Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol (2004) 5.56
SUMO-1 modification activates the transcriptional response of p53. EMBO J (1999) 4.19
Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A (2005) 4.15
ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol (1998) 3.77
The complexity of p53 stabilization and activation. Cell Death Differ (2006) 3.61
Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol (2006) 3.37
Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell (2007) 3.20
Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci U S A (1999) 2.87
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol (2004) 2.50
Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature (1995) 2.47
The p53 functional circuit. J Cell Sci (2001) 2.46
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet (2006) 2.20
Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol (2003) 2.16
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res (2004) 2.08
Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res (2001) 1.93
The absence of SIR2alpha protein has no effect on global gene silencing in mouse embryonic stem cells. Mol Cancer Res (2003) 1.85
Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem (1999) 1.73
Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett (2001) 1.61
Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis (1999) 1.58
Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic Biol Med (2006) 1.48
SirT1 fails to affect p53-mediated biological functions. Aging Cell (2006) 1.33
Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. New Biol (1991) 1.28
Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett (2001) 1.25
Some p53-binding proteins that can function as arbiters of life and death. Cell Death Differ (2006) 1.25
Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription. Circ Res (2000) 1.07
Determination of cellular H2O2 production. Sci STKE (2003) 0.98
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood (2003) 4.19
NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem (2003) 3.98
Modulation of hematopoietic stem cell homing and engraftment by CD26. Science (2004) 3.92
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol (2012) 2.91
Umbilical cord blood transplantation: the first 25 years and beyond. Blood (2013) 2.79
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol (2011) 2.75
Cutaneous dirt-adherent disease with single apparent transverse leukonychia on the fingernails. Arch Dermatol (2009) 2.65
Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol (2007) 2.60
A noncytotoxic DsRed variant for whole-cell labeling. Nat Methods (2008) 2.34
Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation. Cell Stem Cell (2013) 2.12
Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes (2008) 2.00
Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol (2003) 1.80
Immune responses in 4-1BB (CD137)-deficient mice. J Immunol (2002) 1.74
Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. Int J Radiat Oncol Biol Phys (2008) 1.71
Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion (2005) 1.71
The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC Cancer (2010) 1.68
SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells (2005) 1.68
Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol (2002) 1.63
Exenatide-induced eosinophilic sclerosing lipogranuloma at the injection site. Am J Dermatopathol (2014) 1.57
Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol (2006) 1.56
A new angeloylated triterpenoid saponin from the husks of Xanthoceras sorbifolia Bunge. J Nat Med (2009) 1.52
Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev (2007) 1.50
Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat Med (2012) 1.49
Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability. Blood (2007) 1.48
The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J Biol Chem (2004) 1.47
New approaches for improving engraftment after cord blood transplantation. Biol Blood Marrow Transplant (2009) 1.46
Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol (2010) 1.42
Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med (2010) 1.42
Basal cell carcinoma with myoepithelial differentiation. Am J Dermatopathol (2011) 1.40
Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood (2003) 1.40
P21waf-1-Chk1 pathway monitors G1 phase microtubule integrity and is crucial for restriction point transition. Cell Cycle (2002) 1.40
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Eur J Cancer (2010) 1.40
Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol (2002) 1.39
miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun (2009) 1.38
SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood (2010) 1.36
Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest Ophthalmol Vis Sci (2011) 1.35
Vaccinia virus infection modulates the hematopoietic cell compartments in the bone marrow. Stem Cells (2008) 1.33
"Thinking about not-thinking": neural correlates of conceptual processing during Zen meditation. PLoS One (2008) 1.32
Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin. Stem Cells (2007) 1.30
Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood (2009) 1.29
CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood (2007) 1.28
Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. Blood (2002) 1.26
Upregulation of nascent mitochondrial biogenesis in mouse hematopoietic stem cells parallels upregulation of CD34 and loss of pluripotency: a potential strategy for reducing oxidative risk in stem cells. Cell Cycle (2010) 1.25
BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production. Blood (2004) 1.20
Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis. Blood (2004) 1.20
Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells (2013) 1.19
SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells (2014) 1.19
Phthalate concentrations and dietary exposure from food purchased in New York State. Environ Health Perspect (2013) 1.19
Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types. Blood (2013) 1.18
In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem Cells Dev (2013) 1.17
Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist. Support Cancer Ther (2004) 1.16
Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-express fluorescent protein is not. Stem Cells (2006) 1.15
The influence of intense Tai Chi training on physical performance and hemodynamic outcomes in transitionally frail, older adults. J Gerontol A Biol Sci Med Sci (2006) 1.15
AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis. Ann N Y Acad Sci (2007) 1.13
Identification of parameters required for efficient lentiviral vector transduction and engraftment of human cord blood CD34(+) NOD/SCID-repopulating cells. Exp Hematol (2008) 1.13
Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function. J Immunol (2012) 1.13
Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy. Clin Oncol (R Coll Radiol) (2010) 1.12
Sirtuin 1, stem cells, aging, and stem cell aging. Curr Opin Hematol (2008) 1.11
A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures. J Cell Physiol (2004) 1.11
Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation. Biochem Biophys Res Commun (2007) 1.10
Murine embryonic stem cells secrete cytokines/growth modulators that enhance cell survival/anti-apoptosis and stimulate colony formation of murine hematopoietic progenitor cells. Stem Cells (2005) 1.09
Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models. Exp Eye Res (2009) 1.08
Quality of life of medical students in China: a study using the WHOQOL-BREF. PLoS One (2012) 1.06
Tetra-kis[1-phenyl-3-(1H-1,2,4-triazol-1-yl-κN)propan-1-one]bis-(thio-cyanato-κN)manganese(II). Acta Crystallogr Sect E Struct Rep Online (2010) 1.06
Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype. Blood (2012) 1.05
Poly[bis-[μ-1,4-bis-(imidazol-1-yl)butane]dicyanato-cadmium(II)]. Acta Crystallogr Sect E Struct Rep Online (2009) 1.05
CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice. Exp Hematol (2003) 1.05
Overexpression of Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing stem cell repopulation. Blood (2009) 1.04
Identification of small noncoding RNAs in Helicobacter pylori by a bioinformatics-based approach. Curr Microbiol (2009) 1.04
Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential. J Immunol (2005) 1.04
Histamine-induced phosphorylation of the regulatory light chain of myosin II disrupts the barrier integrity of corneal endothelial cells. Invest Ophthalmol Vis Sci (2006) 1.03
Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts. J Biol Chem (2010) 1.03
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer (2011) 1.02
SIRT1 deficiency downregulates PTEN/JNK/FOXO1 pathway to block reactive oxygen species-induced apoptosis in mouse embryonic stem cells. Stem Cells Dev (2011) 1.02
Reliability and sensitivity of the TonoLab rebound tonometer in awake Brown Norway rats. Invest Ophthalmol Vis Sci (2009) 1.01
Serologic survey of the sentinel animals for plague surveillance and screening for complementary diagnostic markers to F1 antigen by protein microarray. Am J Trop Med Hyg (2008) 1.01
Bisphenol A and phthalates and endometriosis: the Endometriosis: Natural History, Diagnosis and Outcomes Study. Fertil Steril (2013) 1.01
The design and synthesis of 9-phenylcyclohepta[d]pyrimidine-2,4-dione derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Org Biomol Chem (2006) 1.00
Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood (2005) 1.00
Enhancement of cell survival by stromal cell-derived factor-1/CXCL12 involves activation of CREB and induction of Mcl-1 and c-Fos in factor-dependent human cell line MO7e. Stem Cells Dev (2004) 1.00
Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. Blood (2003) 1.00
Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway. Int J Biochem Cell Biol (2007) 1.00
A graft-based chemotherapy method for screening effective molecules and rescuing huanglongbing-affected citrus plants. Phytopathology (2012) 0.99
Ex vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG mice. Blood Cells Mol Dis (2011) 0.99
AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice. Exp Hematol (2008) 0.98
Occurrence of eight bisphenol analogues in indoor dust from the United States and several Asian countries: implications for human exposure. Environ Sci Technol (2012) 0.98
Characterization of recombinant lysyl oxidase propeptide. Biochemistry (2010) 0.98
A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry (2006) 0.97
Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisis. Stem Cells Dev (2007) 0.97